Pérez L. Figuero

Concordance between RAS and BRAF mutational status determination in ctDNA and tissue in patients with mCRC

Background Liquid biopsy is a tool that enables identification of diagnostic, prognostic and predictive biomarkers of response to treatment in circulating tumour DNA (ct...

Hernández J. Cruz ;

Brage E. Terán ;

Tocino R. Vidal ;

Francoso A. Rodrígues ;

López B. Rivas ;

Gutiérrez A. López ;

Pérez L. Figuero ;

Ampuero J. Claros ;

García B. Cigarral ;

Sánchez E. Fonseca ;

06/27/2022

Efficacy and safety of anti-PD-1 agents in patients with dMMR metastatic solid tumours: A retrospective, real-world study

Background Immune checkpoint inhibitors (ICIs) have been a revolution in the treatment of solid tumours with a significant increase in overall survival rates. High micro...